Patents by Inventor Vijayalakshmi Shridhar

Vijayalakshmi Shridhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide
    Patent number: 8916199
    Abstract: The invention provides a method of treating ovarian cancer in a mammal, the method inhibits angiogenesis associated with the cancer and comprises the parenteral administration to the mammal of an effective amount of cerium oxide nanoparticles having a predominance of Ce+3.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: December 23, 2014
    Assignee: University of Central Florida Research Foundation, Ind.
    Inventors: Sudipta Seal, Ajay Karakoti, Vijayalakshmi Shridhar, Shailendra Giri
  • TREATING PRE-ECLEMPSIA AND CARDIOVASCULAR DISEASES
    Publication number: 20100196935
    Abstract: This document relates to methods and materials involved in identifying, predicting, and treating pre-eclampsia or a cardiovascular disease (e.g., atherosclerosis) in mammals. For example, methods and materials involved in using serum levels of HtrA polypeptides to identify pre-eclampsia or a cardiovascular disease, using HTRA polymorphisms to predict pre-eclampsia or a cardiovascular disease, and using HtrA antibodies to treat pre-eclampsia or a cardiovascular disease in mammals (e.g., humans) are provided.
    Type: Application
    Filed: March 12, 2008
    Publication date: August 5, 2010
    Applicant: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Vijayalakshmi Shridhar, Jeremy R. Chien, Brian C. Brost, Funminiyi A. Ajayi